Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

UK stock preview: Rolls-Royce, Shell, Avacta

Here are three LSE mainboard stocks to watch this week.

FTSE 100 UK stocks preview share price Shell Rolls royce avacta dividend Source: Bloomberg
  • Rolls-Royce (LON: RR) shares are up 1.5% on Monday morning (06 September 2021)
  • Avacta (LON: AVCT) shares rallied nearly 3% as it made new appointments to its Scientific Advisory Board
  • Shell (LON: RDSA, RDSB) shares rose 0.6% on the confirmation of 2Q 2021’s interim dividend rate
  • Keen to trade these three FTSE 100 stocks? Open an account with us to get started.

Rolls-Royce (LON: RR)

Rolls-Royce Holdings appointed UBS as its joint corporate broker with immediate effect from last Thursday.

UBS will work alongside Morgan Stanley, the Company's existing corporate broker. This means RR’s other long-time house broker Jefferies is out.

This move confirmed earlier reports that the aviation engineer was reportedly seeking to replace its both Jefferies and Morgan Stanley as part of its plans to rebuild its market valuation.

The FTSE 100 company was said to have invited other investment firms to pitch for the position.

One of the first things on UBS’ expected agenda would be to revive investor interest in the Rolls-Royce stock, which has been wiped out by over 50% since the start of the Covid-19 pandemic.

Avacta (LON: AVCT)

Avacta Group has announced new appointments to its Scientific Advisory Board (SAB).

The SAB provides the biotech company’s Therapeutics Division with scientific and clinical advice to support its drug development decision making and pipeline strategy.

The appointments are expected to help further Avacta’s transition into a clinical stage company.

“The wealth of knowledge these individuals will bring, both scientific and clinical, as well as their strategic and commercial insight, will be a major benefit to us as we expand our preclinical programmes and take the next drug candidates into the clinic,” said Dr Alastair Smith, Chief Executive Officer of Avacta Group.

The three new members of the SAB are Professor James Spicer MB., BA., PhD., FRCP, Professor Krishnan Komanduri, MD, and Dr Stéphane Champiat MD, PhD.

What’s your view on these FTSE 100 stocks?

Go short and long with CFDs on 16,000+ shares with the SG’s Best online trading platform.* Learn more about trading shares with us, or open an account to get started today.

* Awarded the Best Online Trading Platform by Influential Brands in 2021.

Shell (LON: RDSA, RDSB)

Royal Dutch Shell’s board has confirmed the pounds sterling and euro equivalent dividend payments in respect of the second quarter 2021 interim dividend at US$0.24 per A ordinary share (A Share) and B ordinary share (B Share).

Dividends on A Shares will be paid, by default, in euros at the rate of €0.2024 per A Share. Holders of A Shares who had validly submitted US dollars or pounds sterling currency elections by 27 August 2021 will be entitled to a dividend of US$0.24 or 17.38p per A Share, respectively.

Dividends on B Shares will be paid, by default, in pounds sterling at the rate of 17.38p per B Share. Holders of B Shares who had validly submitted US dollars or euros currency elections by 27 August 2021 will be entitled to a dividend of US$0.24 or €0.2024 per B Share, respectively.

This dividend will be payable on 20 September 2021 to those members whose names were on the Register of Members on 13 August 2021.

Read more: Top 5 UK stocks to buy in September 2021

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.